US EditionHHS chief RFK Jr. says he’s ordered a ‘complete review’ of chemical abortion pill
- On May 15, 2025, Health and Human Services Secretary Robert F. Kennedy Jr. Instructed FDA Director Marty Makary to thoroughly examine the abortion medication mifepristone and provide a report on his findings.
- Kennedy directed the FDA to review regulations on the abortion pill following a contentious report from a conservative think tank that indicated higher complication rates than those reflected in the agency's official data.
- The study analyzed 865,727 mifepristone abortions from 2017 to 2023, finding 10.93% experienced serious complications versus less than 0.5% in clinical trials.
- Kennedy stated that he has requested FDA Director Marty Makary to conduct a thorough evaluation and provide feedback, adding that the medication’s labeling should be updated to better reflect its associated risks.
- The review could impact access and regulation of mifepristone amid reproductive rights concerns, while Makary said he currently has no plans to restrict the drug's availability.
28 Articles
28 Articles
HHS Secretary Robert F. Kennedy, Jr. Orders Review of Abortion Pill Safety
The Big Pharma-Big Government-Big Media complex cannot be trusted, and its "science" is not trustworthy unless it can be validated or replicated. The post HHS Secretary Robert F. Kennedy, Jr. Orders Review of Abortion Pill Safety first appeared on Le·gal In·sur·rec·tion.
RFK Jr. Announces 'Complete Review' of Abortion Pill After 'Alarming' New Study Reveals Dangers
The Food and Drug Administration will perform a ‘complete review’ of the abortion medication mifepristone, Health and Human Services Secretary Robert F. Kennedy Jr. announced Thursday in a Senate health, Education, Labor and Pensions Committee hearing. RFK Jr.’s announcement was in response to a line of questioning by Senator Josh Hawley. Hawley asked the secretary if he was aware of the recently released study by the Ethics and Public Policy Ce…
U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. Pledges to do a “Complete Review” of Chemical Abortion Pills After New Data Reveals Safety Risks - Students for Life of America
In an explosive development in the ongoing pushback against Chemical Abortion Pills, the head of the U.S. Health and Human Services (HHS), Robert Kennedy Jr., has ordered the Food & Drug Administration (FDA) to conduct a “complete review” of the pills following new reports on their potential dangers. Commenting on new data about adverse health events from taking Chemical Abortion ...
Coverage Details
Bias Distribution
- 58% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
